Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis

Cancer

Volumn 78, Issue 8, 1996, Pages 1660-1665

  Hirota, Chiharu ^a   Lida, Mitsuo ^b   Aoyagi, Kunihiko ^a   Matsumoto, Takayuki ^a   Tada, Shuji ^a   Yao, Takashi ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

familial adenomatous polyposis; indomethacin; rectum; sulindac; therapy

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON RESECTION; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; FAMILIAL COLON POLYPOSIS; FEMALE; HUMAN; HUMAN TISSUE; ILEORECTAL ANASTOMOSIS; MALE; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; RECTUM ADENOMA; RECTUM MUCOSA;

ADENOMATOUS POLYPOSIS COLI; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLECTOMY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INDOMETHACIN; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECTUM; SUPPOSITORIES;

EID: 0029760238     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961015)78:8<1660::AID-CNCR4>3.0.CO;2-I     Document Type: Article

References (22)

1. Ambroze WL Jr., Dozois RR, Pemberton JH, Beart RW Jr., Ilstrup DM. Familial adenomatous polyposis. Results following ileal pouch-anal anastomosis and ileorectostomy. Dis Colon Rectum 1992;35:12-15.
2. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983;24:83-7.
3. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:635-9.
4. Giardiello F, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6.
5. Rigau J, Piqué JM, Rubio E, Planas R, Terrech JM, Bordas JM, et al. Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 1991;115:952-4.
6. Spanesi MT, Tonelli F, Dolara P, Caderni G, Valanzano R, Anastasi A, et al. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Gastroenterology 1994;106:362-6.
7. Winde G, Gumbinger HG, Osswald H, Kemper F, Bünte H. The NSAIDs sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis. Clinical results of a dose-finding study on rectal sulindac administration, Int J Colorectal Dis 1993;8:13-7.
8. Hirata K, Itoh H, Ohsato K. Regression of rectal polyps by indomethacin suppository in familial adenomatous polyposis. Report of two cases. Dis Colon Rectum 1994;37:943-6.
9. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Gerdes J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed sections. J Pathol 1992;168:629-36.
10. Hucker HB, Zachei AG, Cox SV, Brodie DA, Cantwell NH. Studies on the absorption, distribution and excretion of indomethacin in various species. J Pharmacol Exp Ther 1966;153:237-49.
11. Bayer BM, Beaven MA. Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle. Biochem Pharmacol 1979;28:441-3.
12. Uribe A. Indomethacin accelerates clearance of labeled cells and increases DNA synthesis in gastrointestinal tract in rats. Dig Dis Sci 1992;37:403-8.
13. Shiff SJ, Qiao L, Tsai LL, Rigas B. Sulindac sulfide, an aspirinlike compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 1995;96:491-503.
14. Piazza GA, Rahm K, Krutzsch M, Sperl G, Paranka NS, Gross PH, et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 1995;55:3110-6.
15. Bröll H, Eberl R, Sochor H, Tausch G. Verträglichkeit der Langzeittherapie mit indomethacin. Wien Klin Wochenschr 1972;30:421-4.
16. Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 1981;41:1954-7.
17. Pollard M, Luckert PH. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 1981;214:558-9.
18. Giovannucci E, Rimm EB, Stamfer MJ, Colditz GA, Ascherio A, Willett WC, et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
19. Giovannucci E, Egan KM, Hunter DJ, Stamfer MJ, Colditz GA, Willett WC, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-14.
20. Lynch HT, Thorson AG, Smyrk T. Rectal cancer after prolonged sulindac chemoprevention. A case report. Cancer 1995;75:936-8.
21. Niv Y, Fraser GM. Adenocarcinoma in the rectal segment in familial adenomatous polyposis is not prevented by sulindac therapy. Gastroenterology 1994;107:854-7.
22. Thorson AG, Lynch HT, Smyrk TC. Rectal cancer in PAP patient after sulidac. Lancet 1994;343:180.